•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
Gain Therapeutics Shares Drop 14% After Proposed Public Offering News
Gain Therapeutics Announces Proposed Public Offering
Gain Therapeutics shares fall on proposed public offering
Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federation of European Neuroscience Societies (FENS) Forum 2024
Buy Rating Affirmed for Gain Therapeutics Amidst Promising Clinical Trials and Strong Financial Health
Buy Rating Affirmed for Gain Therapeutics Amid Positive Clinical and Financial Performance
Adherex Technologies Inc. (FENC) Lags Q1 Earnings Estimates
Will Gain Therapeutics, Inc. (GANX) Report Negative Q1 Earnings? What You Should Know
Buy Rating Affirmed for Gain Therapeutics on Promising GT-02287 Clinical Progress
Gain Therapeutics Shares Rise 8% After Positive Results From Early Trial of Parkinson's Disease Therapy
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.